The main treatment method for various types of cancer includes immunotherapy to enhance host anti-immunity by blocking programmed cell death protein 1 (PD-1)/anti-programmed death ligand 1 (PD-L1) interaction. This evidence concerns the gene PDCD1 and cancer.